Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis

Journal of Clinical Investigation

Volumn 97, Issue 9, 1996, Pages 2130-2138

  Uyemura, Koichi ^a   Demer, Linda L ^a   Castle, Steven C ^b   Jullien, Denis ^a   Berliner, Judith A ^a   Gately, Maurice K ^c   Warrior, Rajeev R ^c   Pham, Nicole ^a   Fogelman, Alan M ^a   Modlin, Robert L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA ^*  (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cytokine; highly oxidized LDL; minimally modified LDL; monocytes; PCR

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LOW DENSITY LIPOPROTEIN; MESSENGER RNA;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTERFERON INDUCTION; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE INJURY;

EID: 15844415074     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118650     Document Type: Article

References (55)

1. Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. Two types of murine helper T cell clones I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
2. Gately, M.K., B.B. Desai, A.G. Wolitsky, P.M. Quinn, C.M. Dwyer, F.J. Podlaski, P.C. Familletti, F. Sinigaglia, R. Chizzonite, U. Gubler, and A.S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874-882.
3. D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S.H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al. 1992. Production of natural killer cell stimulatory cell factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
4. Germann, T., M.K. Gately, D.S. Schoenhaul, M. Lohoff, F. Mattner, S. Fischer, S. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T-cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not Th2 cells. Eur. J. Immunol. 23:1762-1770.
5. Hsieh, C., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
6. Seder, R.A., R. Gazzinelli, A. Sher. and W.E. Paul. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon-gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
7. Sieling, P.A., X.-H. Wang, M.K. Gately, J.L. Oliveros, T. McHugh, P.F. Barnes, S.F. Wolf, L. Golkar, M. Yamamura, Y. Yogi, et al. 1994. IL-12 regulates T helper Type 1 cytokine responses in human infectious disease. J. Immunol. 153:3639-3647.
8. de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. De Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of 1L-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
9. Barnes, P.F., D. Chatterjee, J.S. Abrams, S. Lu, E. Wang, M. Yamamura, P.J. Brennan, and R.L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol. 149:541-547.
10. D'Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
11. Tripp, C.S., S.F. Wolf, and E.R. Unanue. 1993. Interleukin 12 and tumor necrosis factor-alpha are costimulators of interferon-gamma by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA. 90:3725-3729.
12. de Waal-Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
13. Scott, P., P. Natovitz, R.L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
14. Heinzel, F.P., M.D. Sadick, B.J. Holaday, R.L. Coffman, and R.M. Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
15. Liew, F.Y., S. Millott, Y. Li, R. Lelchuk, W.L. Chan, and H. Ziltener. 1989. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. Eur. J. Immunol. 19:1227-1232.
16. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171:115-127.
17. Boom, W.H., L. Liebster, A.K. Abbas, and R.G. Titus. 1990. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 58:3863-3870.
18. Pearce, E.J., P. Caspar, J.-M. Grzych, F.A. Lewis, and A. Sher. 1991. Downregulation of ThI cytokine production accompanies induction of Th2 responses by a parasitic helmith, Schistosoma mansoni. J. Exp. Med. 173:159-166.
19. Pond, L., D.L. Wassom, and C.E. Hayes. 1989. Evidence for differential induction of helper T cell subsets during Trichinella spiralis infection. J. Immunol. 143:4232-4237.
20. Yamamura, M., K. Uyemura, R.J. Deans, K. Weinberg, T.H. Rea, B.R. Bloom, and R.L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (Wash. DC). 254:277-279.
21. Salgame, P., J.S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R.L. Modlin, and B.R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (Wash. DC). 254:279-282.
22. Sieling, P.A., J.S. Abrams, M. Yamamura, P. Salgame, B.R. Bloom, T.H. Rea, and R.L. Modlin. 1993. Immunosuppressive roles for inlerleukin-10 and interleukin-4 in human infection: in vitro modulation of T cell responses in leprosy. J. Immunol. 150:5501-5510.
23. Clerici, M., D.R. Lucey, J.A. Berzofsky, L.A. Pinto, T.A. Wynn, S.P. Blatt, M.J. Dolan, C.W. Hendrix, S.F. Wolf, and G.M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (Wash. DC). 262:1721-1724.
24. Roach, T.I.A., C.H. Barton, D. Chatterjee, and J.M. Blackwell. 1993. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J. Immunol. 150:1886-1896.
25. Ramshaw, A.L., and D.V. Parums. 1990. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology. 17:543-552.
26. Munro, J.M., J.D. van der Walt, C.S. Munro, J.A. Chalmers, and E.L. Cox. 1987. An immunohistochemical analysis of human aortic fatty streaks. Hum. Pathol. 18:375-380.
27. Emeson, E.E., and A.L. Robertson. 1988. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am. J. Pathol. 130:369-376.
28. Hansson, G.K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
29. Stemme, S., J. Holm, and G.K, Hansson. 1992. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12:206-211.
30. Libby, P., and G.K. Hansson. 1991. Biology of disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64:5-15.
31. Kishikawa, H., T. Shimokama, and T. Watanabe. 1993. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Archiv. A Pathol. Anat. 423:433-442.
32. Berliner, J.A., M.C. Territo, A. Sevanian, S. Ramin, J.A. Kim, B. Bamshad, M. Eslerson, and A.M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
33. Yamamura, M., X.-H. Wang, J.D. Ohmen, K. Uyemura, T.H. Rea, B.R. Bloom, and R.L. Modlin. 1992. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 149:1470-1475.
34. Kosugi, K., D.C. Morel, P.E. DiCorleto, and G.M. Chisolm. 1987. Toxicity of oxidized LDL to cultured fibroblasts is selective for S phase of the cell cycle. J. Cell Physiol. 130:311-320.
35. Hoff, H., T.E. Whitaker, and J. O'Neil. 1992. Oxidation of LDL leads to particulate aggregation and altered macrophage recognition. J. Biol. Chem. 264:602-609.
36. Jougasaki, M., K. Kugiyama, Y. Saito, K. Nakao, H. Imura, and H, Yasue. 1992. Suppression of endothelin-1 secretion by lysophosphatidytcholine in cultured vascular endothelial cells. Circ. Res. 71:614-619.
37. Schuh, J., G.F. Fairclough, and R.H. Haschemeyer. 1978. Oxygen-mediated heterogeneity of apo-low density lipoprolein. Proc. Natl. Acad. Sci. USA. 75:3173-3178.
38. Gately, M.K., and R. Chizzonite. 1992. Measurement of human and mouse interleukin 12. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Marqulies, E.M. Shevach, and W. Stroher, editors. Greene Publishing Associates and Wiley-Interscience, New York. 6.16.1-6.16.8.
39. Desai, B.B., T. Truitt, S. Honasoge, R. Warrier, R. Chizzonite. and M.K. Gately. 1993. Expression of functional IL-12R on a human IL-2-dependent T cell line. J. Immunol. 150:207a (Abstr.).
40. Ku, G., C.A. Thoma, A.L. Akeson, and R.L. Jackson. 1992. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydraxyoctadecadienoic acid. J. Biol. Chem. 267:14183-14188.
41. Witztum, J.L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
42. Parthasarathy, S. 1994. Mechanism(s) of cell-mediated oxidation of low density lipoprotein. In Free Radicals in the Environment, Medicine and Toxicology. H. Nohl, H. Esterbauer, and C. Rice Evans, editors. Richelieu Press, London. 163-179.
43. Witztum, J.L. 1994. The oxidation hypothesis of atherosclerosis. Lancet. 344:793-795.
44. Cushing, S.D., J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, F. Parhami, R. Gerrity, C.J. Schwartz, and A.M. Fogelman. 1990. Minimally modified LDL induces monocyte chemotactic protein 1 in human endothelial and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
45. Rajavashisth, T.B., A. Andalibi, M.C. Territo, J.A. Berliner, M. Navab, A.M. Fogelman, and A.J. Lusis. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature (Lond.). 344:254-257.
46. Schwartz, D., A. Andalibi, L. Chaverri-Almada, J A. Berliner, T. Kirchgessner, Z.T. Fang, P. Tekamp-Olson, A.J. Lusis, C. Gallegos, A.M. Fogelman, and M.C. Territo. 1994. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J. Clin. Invest. 94:1968-1973.
47. McMurray, H.F., S. Parthasarathy, and D. Steinberg. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1004-1008.
48. Frostegard, J., J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, and M. Gidlund. 1990. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and monocytic cell line U937. Proc. Natl. Acad. Sci. USA. 87:904-908.
49. Terkeltaub, R., C.L. Banka, J. Solan, D. Santoro, K. Brand, and L.K. Curtiss. 1994. Oxidized LDL induces monocytic cell expression of interleukin-8, a chermokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14: 47-53.
50. Stemme, S., B. Faber, J. Holm, O. Wiklund, J.L. Witztum, and G.K. Hansson. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl. Acad. Sci. USA. 92:3893-3897.
51. Xu, Q., R. Kleindienst, W. Waitz, H. Dietrich, and G. Wick. 1993. Increased expression of heal shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91:2693-2702.
52. Kleindienst, R., Q. Xu, J. Willeit, F.R. Waldenberger, S. Weimann, and G. Wick. 1993. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am. J. Pathol. 142:1927-1937.
53. van der Wal, A.C., A.E. Becker, C.M. van der Loos, and P.K. Das. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:36-44.
54. Henney, A.M., P.R. Wakeley, M.J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. 1991. Localization of stromelysin gene expression in atherosclerotic plaques. Proc. Natl. Acad. Sci. USA. 88:8154-8158.
55. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549-1555.